Creative Biolabs has invited Dr. Magnus A.G. Hoffmann to walk us through the application of hybrid mRNA technology in vaccine development, strategies for optimizing hybrid mRNA vaccines, and the use of this technology in developing pan-coronavirus vaccines.

During this webinar, we will explore the following key topics:

Description and development of the hybrid mRNA technology that combines features of mRNA- and protein nanoparticle-based vaccines
In vivo evaluation of the hybrid mRNA technology for SARS-CoV-2 in mice, including new data on hybrid mRNA-based booster immunizations in pre-vaccinated mice
Optimization strategies for hybrid mRNA vaccines, including preliminary data on new designs that enhance expression
Application of the hybrid mRNA vaccine technology as a pan-coronavirus vaccine platform

Register now to secure your spot: https://mrna.creative-biolabs.com/eabr-nanoparticles-as-a-platform-technology-for-hybrid-mrna-vaccine.htm